Silent Ureteral Stone: Impact on Renal Function and Kidney Anatomy
NCT ID: NCT01884870
Last Updated: 2015-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
25 participants
INTERVENTIONAL
2012-11-30
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Total Nephrectomy on Patients With Kidney Stone
NCT01235104
ESWL vs URS in Management of Upper Third Ureteric Calculi
NCT03559738
Comparison Between Two Shock Wave Regimens for Treating Urinary Stones
NCT01222325
Ureteral Stent Versus Percutaneous Nephrostomy in Acutely Obstructed Infected Kidney
NCT03498794
A Multicenter Prospective Research on the Treatment of Low Pole Renal Calculus by Flexible Ureteroscope
NCT03105206
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The situation becomes even more distressing when managing asymptomatic stones. Studies of the natural history of stones have revealed that only 20% of patients yearly actually become symptomatic from a new stone, and one half of those require surgical intervention at some point. The guidelines are well established for the treatment of symptomatic urolithiasis, and many investigators have extensively studied the management of silent kidney stones. Conversely, the same is not true for silent ureterolithiasis. The purpose of the present study is to report the investigators experience managing silent ureteral stones and to prospectively analyze their true influence on renal function.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical Treatment
Silent Ureteral Stone - Surgical Treatment
Surgical Treatment
Surgical Treatment - open, endoscopic or laparoscopic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgical Treatment
Surgical Treatment - open, endoscopic or laparoscopic
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient willing to participate in the study
* Complete pre/post-operative work-up
Exclusion Criteria
* No will to be a part of the study
* Incomplete pre/post-operative work-up
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giovanni Scala Marchini
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giovanni S Marchini, MD
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinics Hospital - University of Sao Paulo Medical School
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Online Number: 9015
Identifier Type: REGISTRY
Identifier Source: secondary_id
CAAE: 01187012.2.0000.0068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.